Research priorities to prevent and treat diabetic foot ulcers-A digital James Lind Alliance Priority Setting Partnership.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
11 2022
Historique:
received: 17 02 2022
accepted: 26 08 2022
pubmed: 3 9 2022
medline: 15 10 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

To establish outcomes of a priority setting partnership between participants with diabetes mellitus and clinicians to identify the top 10 research priorities for preventing and treating diabetic foot ulcers (DFUs). Due to the COVID-19 pandemic, the James Lind Alliance Priority Setting Partnership process was adapted into a digital format which involved a pilot survey to identify understandable uncertainties with high relevance for participants tested by calculating the content validity index; a main survey answered by 53 participants living with diabetes and 49 clinicians; and a final digital workshop to process and prioritise the final top 10 research priorities. The content validity index was satisfactory for 20 out of 25 uncertainties followed by minor changes and one additional uncertainty. After we processed the 26 uncertainties from the main survey and seven current guidelines, a list of 28 research uncertainties remained for review and discussion in the digital workshop. The final top 10 research priorities included the organisation of diabetes care; screening of diabetes, impaired blood circulation, neuropathy, and skin properties; vascular surgical treatment; importance of self-care; help from significant others; pressure relief; and prevention of infection. The top 10 research priorities for preventing and treating DFUs represent consensus areas from persons living with diabetes and clinicians to guide future research. These research priorities can justify and inform strategic allocation of research funding. The digitalisation of James Lind Alliance methodology was feasible.

Identifiants

pubmed: 36054410
doi: 10.1111/dme.14947
pmc: PMC9826297
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14947

Informations de copyright

© 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Références

Lancet Diabetes Endocrinol. 2019 Dec;7(12):938-948
pubmed: 31624024
Diabetes Care. 2022 Jan 1;45(1):83-91
pubmed: 34782354
Wounds. 2019 Jul;31(7):173-178
pubmed: 31184593
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266
pubmed: 32176447
Int J Low Extrem Wounds. 2020 Jun;19(2):165-179
pubmed: 31973632
Gerodontology. 2015 Sep;32(3):222-8
pubmed: 26009973
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3269
pubmed: 32176451
Diabet Med. 2022 Nov;39(11):e14947
pubmed: 36054410
Eur J Vasc Endovasc Surg. 2017 Feb;53(2):206-213
pubmed: 27889202
Lancet. 2005 Nov 12;366(9498):1719-24
pubmed: 16291066
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3283
pubmed: 32176450
JAMA. 2021 Aug 24;326(8):736-743
pubmed: 34427594
Fam Pract. 1993 Mar;10(1):76-81
pubmed: 8477899
J Vasc Surg. 2020 Apr;71(4):1433-1446.e3
pubmed: 31676181
Diabetes Metab Res Rev. 2019 Sep;35(6):e3160
pubmed: 30916434
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):743-747
pubmed: 27997725
Diabet Med. 2012 Oct;29(10):1321-6
pubmed: 22823450
Int Wound J. 2019 Feb;16(1):183-210
pubmed: 30393976
Diabet Med. 2018 Jul;35(7):862-870
pubmed: 29485717
SAGE Open Med. 2019 Jan 01;7:2050312118822632
pubmed: 30637104
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280
pubmed: 32176444
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3270
pubmed: 31957213
Science. 2020 Apr 24;368(6489):353
pubmed: 32327577
Diabetologia. 2018 Dec;61(12):2590-2597
pubmed: 30171278
Acta Diabetol. 2021 Jun;58(6):735-747
pubmed: 33547497
Res Nurs Health. 2006 Oct;29(5):489-97
pubmed: 16977646
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3276
pubmed: 31958217
Vascular. 2021 Oct;29(5):693-703
pubmed: 33190618
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3274
pubmed: 32176441

Auteurs

Christine Kumlien (C)

Department of Care Science, Malmö University, Malmö, Sweden.
Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Malmö, Sweden.

Stefan Acosta (S)

Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Malmö, Sweden.
Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.

Sebastian Björklund (S)

Department of Biomedical Science, Malmö University, Malmö, Sweden.
Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.

Eva Lavant (E)

Department of Biomedical Science, Malmö University, Malmö, Sweden.
Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.

Victoria Lazer (V)

Department of Care Science, Malmö University, Malmö, Sweden.

Johan Engblom (J)

Department of Biomedical Science, Malmö University, Malmö, Sweden.
Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.

Tautgirdas Ruzgas (T)

Department of Biomedical Science, Malmö University, Malmö, Sweden.
Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden.

Magdalena Gershater (M)

Department of Care Science, Malmö University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH